PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED EXTREMITY/TRUNK WALL SOFT TISSUE SARCOMAS: EARLY STUDY RESULTS - PowerPoint PPT Presentation

About This Presentation
Title:

PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED EXTREMITY/TRUNK WALL SOFT TISSUE SARCOMAS: EARLY STUDY RESULTS

Description:

Improved survival with radiation therapy in high-grade ... Background Can we shorten the overall treatment time by using hypofractionated radiotherapy and ... – PowerPoint PPT presentation

Number of Views:81
Avg rating:3.0/5.0
Slides: 35
Provided by: hk52
Learn more at: https://www.ctos.org
Category:

less

Transcript and Presenter's Notes

Title: PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED EXTREMITY/TRUNK WALL SOFT TISSUE SARCOMAS: EARLY STUDY RESULTS


1
PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN
LOCALIZED EXTREMITY/TRUNK WALLSOFT TISSUE
SARCOMASEARLY STUDY RESULTS
Hanna Kosela Milena Kolodziejczyk Tadeusz
Morysinski Wirginiusz Dziewirski
Marcin Zdzienicki Piotr Rutkowski Department of
Soft Tissue/Bone Sarcoma and Melanoma,
Department of Radiotherapy Maria
Sklodowska-Curie Memorial Cancer Center and
Institute of Oncology Warsaw, Poland
2
Background
  • Primary treatment of majority of localized soft
    tissue sarcoma is surgical resection of the tumor
    with adequate margins combined with radiotherapy
  • Using radiotherapy in the local setting increases
    local control of the disease (with suggested
    survival benefit for patients with high grade
    tumors)
  • Koshy M,  et al. . Improved survival with
    radiation therapy in high-grade soft tissue
    sarcomas of the extremities a SEER analysis. Int
    J Radiat Oncol Biol Phys. 2010 May 177(1)203-9

3
Background preoperative radiotherapy vs
postoperative setting
Benefits Drawbacks
Lower doses and smaller treatment field size Possible improvement in tumor resectability Smaller incidence in long term radiation- related complications Increased risk of wound complications
No differences in local recurrence rate,
regional and distant failure rates O'Sullivan
B, et al. . Preoperative versus postoperative
radiotherapy in soft-tissue sarcoma of the limbs
a randomised trial.2002 Jun 29359(9325)2235-41.
4
Background
  • Can we shorten the overall treatment time by
    using hypofractionated radiotherapy and immediate
    surgery in STS as in rectal carcinoma?
  • Potential benefits
  • Lower risk of tumor clonogens repopulation
  • Convenience
  • Lower cost
  • Radiobiological rationale low a/ß ratio -0,5-5
    Gy
  • Gunderson LL, Tepper JE. Clinical Radiation
    Oncology. London, UK ChurchillLivingstone 2007

5
AIM OF THIS PILOT STUDY
  • Incidence of late complicatons and local
    recurrences compared to those observed after
    conventionally fractionated preoperative
    radiotherapy.
  • Overall survival

6
Patients and methods
In the years 2006-2010, 262 patients received 5x5
Gy according to uniform internal preoperative
protocol and underwent tumor resection within a
consecutive week. In our analysis we included
only patients with diagnosis of localized,
resectable soft tissue sarcoma of the extremities
or trunk wall (confirmed pathologically) primary
or recurrent deep seated and/or
intermediate/high grade
7
Patients and methods
  • 225 patients
  • 122 (54) women, 103 (46) men
  • Median age 54 years (range 18-82)
  • Median follow up 34 months (range 1-80)
  • Bioethical committee approval

8
Patients and methods
  • 140 patients (62.2)- primary tumors
  • 75 patients (33) clinical local recurrence
    after previous surgery in another center
  • 10 patients (4.4)- after non-radical surgery in
    another center, but without clinical recurrence
    (scar)
  • 56 (24.9) patients received preoperative
    chemotherapy
  • 75 of these patients had high grade tumors (G3)

9
Patients and methods
10
Patients and methods
Synovial sarcoma
11
Patients and methods
16 patients had also postoperative radiotherapy
12
Results
  • 51 (22.6) patients were dead at the time of
    analysis
  • 93 (41.3) recurrences of the disease
  • 46 - local recurrence (20 local recurrence
    80 local control rate) - in 10 patients after
    local recurrence amputation was performed
  • 78 (34.7)- distant metastases
  • 31 (13.8) patients had local and distant
    recurrence of the disease

13
70
14
80
15
Factors influencing survival (univariate analysis)
  • OS
  • Tumor size (p 0.05)
  • Tumor grade (p 0.0002)
  • LRFS
  • - Tumor grade (p 0.007)

16
(No Transcript)
17
(No Transcript)
18
p0.05
19
(No Transcript)
20
(No Transcript)
21
80
60
22
75
57
23
(No Transcript)
24
(No Transcript)
25
(No Transcript)
26
Complications of the treatment
97 patients (43) had postoperative wound
complications including 9 patients (4) who
required an additional surgical procedure 33.6
of patients with complications received
preoperative chemotherapy 87 patients with
wound complications (89.6) had tumor localized
on the lower limb
27
Early local complications
  • 38 (16.9) patients had prolonged healing of the
    wound (gt1 month)
  • 28 (12.4) patients had wound dehiscence
  • 9 (4) patients required prolonged punctures of
    the collecting lymph fluid
  • 6 (2.7) patients had an increased acute skin
    toxicity

28
Late complications
  • 2 (0.8) patients severe fibrosis leading to
    contracture of the limb
  • 24 (10.7) patients prolonged edema of the
    operated limb
  • 6 (2.7) patients - fracture of the treated limb
    (median time from treatment to fracture 18 months)

29
Discussion
30
Discussion
31
Conclusions
  • Local control rates an overall survival similar
    to those seen in patients treated with
    preoperative radiotherapy conventionally
    fractionated
  • Our series comprises majority of high risk
    patients with large high grade tumors
  • Wound complication - quite high rate of early
    complications but low percentage of severe
    complications
  • Late complications - similar to those seen in
    patients treated with preoperative radiotherapy
    conventionally fractionated

32
Clinical trial? Short-course preoperative
radiotherapy vs conventional radiotherapy
33
ACKNOWLEDGEMENTS
  • Cancer Center Institute Warsaw
  • K. Wiater, S. Falkowski, A. Klimczak, T. Switaj,
    K. Ptaszynski,
  • U. Grzesiakowska, E. Bylina,
  • A, Gluszcz,
  • Our patients and their families

34
Cancer Center, Warsaw, Poland
Thank you for your attention!
Write a Comment
User Comments (0)
About PowerShow.com